You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Turkey sees sharp rise in obesity
- 2. ASCO 2025: Risk of fourteen obesity-related cancers for people with diabetes
- 3. Biden says he's 'feeling good' in first remarks after cancer diagnosis
- 4. Biden Somehow Says ‘I Don't Have Any Regrets' About Running for Reelection
- 5. ASCO 2025: Trial shows biomarkers hold clue in treating aggressive prostate cancer
- 6. Clinical Trials Demonstrate Monitoring PD-L1 Upregulation Using LifeTracDx Blood Test Could Support New Treatment Path for Metastatic Triple Negative Breast Cancer
- 7. ASCO 2025: Menopause drug duavee may help prevent invasive breast cancer
- 8. New IMV Study Reveals Key Trends in U.S. Breast Imaging: Procedure Growth, Equipment Plans, and Patient Priorities
- 9. Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
- 10. New three-drug combination 'could help women with aggressive breast cancer live longer'
Last updated at 18:14 GMT
Hot News Makers
Health/Pharma Companies
-
77325.50
-
9898.77
-
3270.29
-
2752.51
-
2661.54
-
1969.39
-
1864.91
-
1672.34
-
1107.52
-
1081.15
Drugs, Treatments, Trials
-
12170.23
-
9733.04
-
6318.52
-
4699.18
-
3223.81
-
2414.97
-
1402.42
-
935.03
-
813.88
-
771.19
Last updated at 17:10 GMT
